Type 2 diabetes and obesity patients
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes or obesity who were hospitalized in Tokyo Medical and Dental University Hospital for the purpose of glycemic control or weight reduction.
Exclusion criteria
Exclusion criteria: Patients with severe renal impairment (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2 or undergoing renal replacement therapy), pregnant women, and those with infectious or malignant diseases were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The changes of body weight, appendicular lean soft tissue mass and body fat percentage during 6 months follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes of visceral and subctaneous fat area during 6 months follow-up. | — |
Countries
Japan
Contacts
Tokyo Medical and Dental University Department of Molecular Endocrinology and Metablism